Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.89 USD | +1.43% | -1.59% | -11.42% |
Evolution of the average Target Price on Catalyst Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Catalyst Pharmaceuticals, Inc.
Citigroup | |
BofA Securities | |
Cantor Fitzgerald | |
Oppenheimer | |
Truist Securities | |
HC Wainwright | |
Piper Sandler | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- CPRX Stock
- Consensus Catalyst Pharmaceuticals, Inc.